# Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care

> **NCT07699640** · NA · NOT_YET_RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 171 (estimated)

## Conditions studied

- Testicular Cancer
- Testicular Germ Cell Tumor

## Interventions

- **PROCEDURE:** ICG-Guided Retroperitoneal Sentinel Lymph Node Biopsy
- **PROCEDURE:** Radical Inguinal Orchiectomy

## Key facts

- **NCT ID:** NCT07699640
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2029-01
- **Final completion:** 2031-01
- **Target enrollment:** 171 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699640, "Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*